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Abstract
Background In the context of von Hippel-Lindau disease
(VHL), the medulla oblongata is a relatively frequent site of
growth of hemangioblastomas, posing related clinical and
surgical difficulties. Their management requires a close
correlation between clinical evolution and morphological
surveillance. In order to describe their clinical and surgical
features, we reviewed our experience in the treatment of these
lesions.
Methods Between 2001 and 2009, 14 patients (9 female
and 5 male, mean age 34 years) underwent removal of 15
lower brain stem hemangioblastomas. Based on the review
of the clinical records and outpatient long-term follow-up
visits, their clinical course was analyzed. Functional
evaluation was measured with the Karnofsky Performance
Scale (KPS) on admission, at discharge and at the last
follow-up. The mean follow-up period was 30.8 months
(range 4–99).
Results All the operated hemangioblastomas were located in
the dorsal medulla oblongata, in the context of multiple
lesions, cerebellar and/or spinal. In ten patients hemangio-
blastomas were located in a median position at the obex area;
in four cases a lateral location was observed. Cystic
component was absent in two cases. Clinical onset preceded
surgery by a mean of 8.5 months. Preoperatively three patients
showed a KPS lower than 80, ten patients between 80 and 90,
and one patient scored 100 (asymptomatic). There was no
surgical mortality. Nine out of 14 patients showed a temporary
surgical morbidity. One patient required a tracheostomy. At
follow-up ten patients scored a KPS better than before the
operation, while the other four patients remained stable.
Permanent morbidity was observed in three patients.
Conclusions Lower brain stem hemangioblastomas in the
context of VHL show an often gradual onset of signs and
symptoms except for patients who develop an obstructive
hydrocephalus. Although transient surgical complications
are possible, surgery provides favorable long-term results.
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Introduction
Although hemangioblastomas are histologically benign
tumors, their operative management can be challenging,
especially with brain stem locations. Since VHL patients
frequently harbor multiple hemangioblastomas, surgery is
recommended for symptomatic or rapidly growing lesions
in a complex clinical context, requiring a close MR-based
imaging follow-up [1, 15].
CNS involvement in VHL comprises, in order of
frequency, cerebellar, spinal, brain stem and supratentorial
hemangioblastomas. Brain stem hemangioblastomas fre-
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quently grow in the lower third of the brain stem, at the
obex or in the postero-lateral aspect of the medulla
oblongata [4]. The aim of this study was to review all
patients with VHL disease-associated medullary hemangio-
blastomas who underwent surgery in our neurosurgical unit,
in order to highlight their clinical behavior and to assess the
safety and efficacy of surgical treatment.
Patients and methods
Since von Hippel-Lindau disease is a neoplastic autosomal-
dominant syndrome predisposing the patients to develop CNS
hemangioblastomas and several lesions in many organs,
affected individuals are periodically followed by a multi-
specialist team, composed of endocrinology, neurosurgery,
urology and nephrology, ophthalmology, general surgery,
radiology and molecular genetic specialists (VHL Padua
network). The evaluation protocol includes VHL genetic
testing, blood and urinary analysis, audiometric and ophtal-
mological examinations; cerebral, spinal and abdominal MRs
are obtained. Follow-up evaluations are planned at intervals of
3, 6, 12 and 24 months, and then every 2 years unless closer
examinations are necessary. Since 2000 the VHL Padua
Network has been following 120 affected individuals. A
medullary location of CNS hemangioblastomas was found in
22 individuals (18%) in our patient population; among them
14 individuals were submitted to surgical removal of a lower
brain stem hemangioblastoma (6 patients were part of a
previously published series [15]). Their overall physical
conditions were scored according to KPS at the moment of
admission, at discharge and during the last follow-up
evaluation. All patients with brain stem hemangioblastomas
presented one or more other CNS lesions (without consid-
ering retinal angiomas). A complete molecular analysis of
the VHL gene obtained in each patient confirmed the genetic
diagnosis. All patients were operated on by the same surgeon
(GP). Preoperative angiography, endovascular embolization,
intraoperative monitoring and ultrasonography were never
utilized. Three patients showed hydrocephalus on admission,
with one requiring an external ventricular drainage. Lesions
were approached through a suboccipital craniotomy tailored
on an individual basis in case of multiple lesions, and
enlarging the caudal exposure by C1 laminectomy and C2
partial drilling if necessary. A sitting position was preferred,
while patients with already implanted ventriculo-peritoneal
shunts were positioned prone.
Results
The mean interval time lasting from the first symptoms'
onset and operation was 8.5 months (range 0–24). One
patient was asymptomatic, and the decision to operate was
based on a progressive increase of the solid hemangioblas-
toma on serial MR imaging. The most frequent preoperative
symptoms included headache and cervical pain, followed
by long tract signs and nuclear involvement (Fig. 1).
Preoperatively three patients showed a KPS lower than
80, ten patients between 80 and 90, and one patient scored
100 (asymptomatic). Hemangioblatomas were located at the
obex area in ten cases and along the dorso-lateral aspect of
the bulb in four cases. They were mainly dorsal exophytic
(Fig. 2), while a focal intramedullary situation was less
common (four cases). Maximum diameter of the nodule
ranged between 3 and 21 mm. In two cases only the solid
component of the hemangioblastoma was found. In one
patient two hemangioblastomas within the bulbar syrinx
were removed. In five patients intraoperative episodes of
bradycardia occurred during tumor dissection; they were
managed pharmacologically and by reducing surgical
traction.
During the postoperative course only three patients
required prolonged monitoring in the intensive care unit
(ICU): one for a tracheostomy (16 days), another for a close
monitoring of external ventricular drainage (4 days) and a
third for hyponatremia (3 days). The other 11 patients were
discharged to a regular ward the day after surgery. Mean
length of ICU occupancy was 2.4 days. A transient
postoperative morbidity (new symptoms or worsening of
pre-existing symtoms) was observed in nine patients (64%):
paresis and hypoesthesia of the hand and lower cranial
nerve functional impairment were the more common
complaints. At follow-up 11 patients (78.5%) showed no
residual neurological deficit related with the brain stem
hemangioblastoma, while three patients showed a stable
neurological deficit (one diplopia, one paresis and hypo-
esthesia of the hand, and one mild swallowing impairment).
Considering long-term functional outcome, ten patients
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Fig. 1 Preoperative symptoms and their frequency
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scored a KPS better than before the operation, and four
patients remained stable. When comparing long-term KPS
with KPS at discharge, one patient showed a worsened KPS
at follow-up because of clinical progression of multiple
cervical hemangioblastomas (patient no. 5, Table 1). MR
follow-up confirmed the total excision of the operated
hemangioblastomas, the disappearance of the associated
cyst and resolution of hydrocephalus whenever present
(Fig. 3). Table 1 summarizes the most relevant clinical
features of our patients.
Discussion
Clinical presentation
In our experience 18% of patients with VHL show lower
brain stem localization of hemangioblastomas. Other series
report comparable figures [4, 6, 9, 17]. Thus, when dealing
with VHL disease, symptoms and signs correlated with
bulbar function should be investigated carefully, since they
may be difficult to assess during standard neurological
examinations. In particular, food aversion with body weight
loss and stomach ache is a misleading clinical onset related
with vagal nuclear involvement by obex compression [14,
19]. Even though our series is homogeneous for what
concerns the anatomical site of growth, preoperatively we
observed an assortment of different clinical features that
can be explained by the functionally crowded area of the
dorsal medulla oblongata.
Also the interval between clinical onset and surgery is
variable, ranging from weeks to years. Our observations
concerning the clinical progression of neurological symp-
toms are considerably influenced by the close surveillance
to which these patients are submitted once VHL diagnosis
is established, and, therefore, their therapeutic management
is generally shortened in terms of surgical timing. However,
it is noteworthy that 11/14 patients (78%) showed a KPS
between 80 and 100 before surgery, meaning that they were
able to carry on normal activities in the presence of at least
some minor symptoms. These remarks suggest that brain
stem hemangioblastomas behave as slow-growing tumors
causing a gradual clinical progression, which usually allows
an elective surgery setting. Conversely, in three cases we
observed a rapid clinical onset, correlated with obstructive
hydrocephalus development, requiring an early timing of
surgery.
Surgical outcome
Operability assessment for brain stem hemangioblastomas
in VHL patients develops out of a multiorgan pathology
and in a context of multiple CNS lesions. The natural
history of hemangioblastomas in VHL is characterized by
the alternation of variable periods of quiescence and
periods of growth [1, 18, 23], making the prognosis of the
Fig. 2 Preoperative contrast-
enhanced MR (a, b) showing a
typical hemangioblastoma at the
obex with an exophytic location
and an associated bulbar syrinx;
1 year after surgery MR (c, d)
showing complete removal of the
lesion and disappearance of the
cystic component (patient no. 9)
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clinical picture difficult to assess. Especially the concom-
itancy of other symptomatic CNS hemangioblastomas
makes it difficult to evaluate the clinical priority among
different localizations. Anyway, although VHL disease has
a severe impact on long-term prognosis in relation to
median length of life [10], what emerges from the literature
[13, 26] and from our observations is that VHL patients
with symptomatic or growing bulbar hemangioblastomas
are young adult patients that benefit from surgical resection
of these lesions in terms of symptom recovery or
stabilization. There are previous reports regarding surgery
of brain stem hemangioblastomas showing the efficacy of
microsurgical treatment, but without distinguishing be-
tween VHL-associated and sporadic hemangioblastomas
[2, 20, 21, 24]; actually, it has been observed that there is
no difference in terms of functional outcome between VHL
and non-VHL patients with surgically treated medulla
oblongata hemangioblastomas [13]. Weil et al. [26]
reported a series of 12 VHL patients operated on for brain
stem hemangioblastomas with a final surgical outcome (11/
12 remained stable or improved) similar to our observa-
tions, although we, as well as other authors [2, 16, 21, 24,
27], noted a higher rate of postoperative transient morbid-
ity; at follow-up all our patients were stable (4 patients) or
improved (10 patients) when compared with preoperative
overall conditions. Thus, microsurgery, with the support of
adequate postoperative care to manage transitory failures of
neurological functions, offers a safe and effective treatment
in these patients. Persistent neurological sequelae are more
probably linked to the degree of tumor adhesion to the floor
of the inferior triangle of fourth ventricle, and the
consequent difficulty in leaving the neural tissue intact,
however delicate the dissection. Therefore, it appears that a
key role in the management of brain stem hemangioblas-
tomas is played by serial combined clinical and MR-
imaging surveillance in these patients, allowing an early
diagnosis and the choice of the most appropriate timing for
surgery, in order to avoid severe clinical deterioration
before treatment. Thus, we recommend surgical therapy
when brain stem symptoms correlate with MR findings or
when the solid lesion or the associated cyst show a
significant volume increase even in asymptomatic patients.
Surgical technique
Concerning the surgical management, our patients were
treated without intra-operative monitoring: even if this
technological innovation may help direct surgery in highly
functional areas, in the specific case of hemangioblastomas
its use is not mandatory since (1) there is no problem of
visual demarcation between tumor and normal tissue; (2) a
superficial part of the lesion is usually apparent once the
dura is opened and/or entering the associated cyst may help
to reach a deeper location; (3) any attempt of partial
Table 1 Clinical findings of patients operated on for brain stem hemangioblastoma
Patient
no.
Age Clinical onset
(months)
Location Preop
KPS
Discharge
KPS
Last
follow-up
KPS
Temporary
complications
Persistent
deficits
Follow-up
(months)
1 23 24 Median 10 50 60 Lower cranial nerves
palsy, diplopia
Diplopia 99
2 34 5 Lateral 80 90 100 Hand paresis and
paresthesia
96
3 47 3 Median 90 100 100 52
4 30 1 Lateral 70 100 100 Lower cranial nerves
palsy
42
5 28 18 Median 80 100 80 27
6 25 0 Median 100 100 100 25
7 30 6 Lateral 80 80 80 19
8 31 14 Median 80 80 90 17
9 29 1 Median 90 80 90 Diplopia, hand paresis,
lower cranial nerves
Swallowing
discomfort
15
10 31 12 Median 80 100 100 Hand paresis and
dysesthesia
13
11 56 1 Median 30 100 100 Hiccup, dysphonia 13
12 22 3 Median 80 90 90 Hand paresis and
dysesthesia
Hand paresis 12
13 50 3 Median 80 80 90 Cerebellar ataxia 11
14 35 20 Lateral 80 90 90 Vertigo 4
KPS = Karnofsky Performance Status
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surgical removal must be avoided owing to the conspicuous
vascularization of these tumors. Actually, it is crucial to
find and follow the arachnoidal plane that, under high
magnification, always marks the boundary between the
lesion and neural tissue. Intraoperative bradycardia may
occur, and it always is resolved either pharmacologically or
by reducing undue distraction of the surrounding nerve
pathways during dissection of the lesion. Intraoperative
bleeding is not a major concern since the lesion is handled
gently and not entered during its progressive devasculariza-
tion conducted by properly low-set bipolar coagulation;
whenever hemorrhage occurs during tumor dissection,
cottonoid compressive hemostasis is usually an adequate
means to keep the operative field clear until devasculariza-
tion is completed. Although cyst excision was not usually
attempted, in two cases it was necessary to open its wall
wide with the purpose of releasing a trapped fourth
ventricle. After surgery these patients need careful neuro-
logical monitoring, especially for the risk of transient
difficulties in swallowing and raising sputum, which may
need specific prophylactic and rehabilitative measures in
order to avoid aspiration pneumonia.
Treatment alternatives
Some authors consider radiosurgery for intracranial heman-
gioblastomas [8, 12, 22, 25], but experience with the brain
stem location is limited: the presence of an often symp-
tomatic cystic component and the functional eloquence of
the surrounding tissue seems to restrict the long-term
efficacy and the safety of radiosurgery for lower brain stem
hemangioblastomas [3, 7, 11]. Since microsurgery provides
safe, immediate and complete cure of the lesion, we believe
that it is the first-choice therapeutic option and that
radiosurgery for brain stem hemangioblastomas may play
a role for patients who are not surgical candidates [5].
Conclusions
Lower brain stem hemangioblastomas in the context of
VHL show an often gradual onset of signs and symptoms
except for patients who develop an obstructive hydroceph-
alus. Serial clinical and MR-imaging examinations are
essential to provide early diagnosis and appropriate thera-
Fig. 3 Clinical and radiological progression of a medullary heman-
gioblastoma (patient no. 11): asymptomatic small hemangioblastoma
at the obex (a); acute hydrocephalus associated with an increase in
volume of the nodule (b); hydrocephalus resolution after complete
removal of the tumor
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peutic decisions. Although transient surgical complications
are possible, surgery offers complete removal with accept-
ably low risk, achieving favorable long-term results.
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